Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Linsitinib | 0.031623 | uM | 7 | 156.25 | 15.92 | 335.00 | 194.50 | 1.7224 | 1.3250 |
| MCF 10A | 17-AAG | 10 | uM | 7 | 156.25 | 15.92 | 36.00 | 194.50 | 0.1851 | 0.2536 |
| MCF 10A | Lapatinib | 0.1 | uM | 7 | 156.25 | 15.92 | 400.00 | 194.50 | 2.0566 | 1.4420 |
| MCF 10A | 17-AAG | 0.31623 | uM | 7 | 156.25 | 15.92 | 21.00 | 194.50 | 0.1080 | 0.0798 |
| MCF 10A | Linsitinib | 10 | uM | 7 | 156.25 | 15.92 | 72.00 | 194.50 | 0.3702 | 0.5189 |
| MCF 10A | Linsitinib | 0.31623 | uM | 7 | 156.25 | 15.92 | 132.00 | 194.50 | 0.6787 | 0.7964 |
| MCF 10A | Erlotinib | 0.31623 | uM | 7 | 156.25 | 15.92 | 119.00 | 194.50 | 0.6118 | 0.7456 |
| MCF 10A | Erlotinib | 3.1623 | uM | 7 | 156.25 | 15.92 | 24.00 | 194.50 | 0.1234 | 0.1205 |
| MCF 10A | Erlotinib | 1 | uM | 7 | 156.25 | 15.92 | 27.00 | 194.50 | 0.1388 | 0.1576 |
| MCF 10A | 0 | uM | 7 | 156.25 | 15.92 | 191.00 | 194.50 | 0.9820 | 0.9900 | |
| MCF 10A | 0 | uM | 7 | 156.25 | 15.92 | 3.00 | 194.50 | 0.0154 | -0.3701 | |
| MCF 10A | 0 | uM | 7 | 156.25 | 15.92 | 2.00 | 194.50 | 0.0103 | -0.4370 | |
| MCF 10A | 0 | uM | 7 | 156.25 | 15.92 | 111.00 | 194.50 | 0.5707 | 0.7123 | |
| MCF 10A | Linsitinib | 3.1623 | uM | 7 | 156.25 | 15.92 | 43.00 | 194.50 | 0.2211 | 0.3168 |
| MCF 10A | Linsitinib | 0.01 | uM | 7 | 156.25 | 15.92 | 103.00 | 194.50 | 0.5296 | 0.6772 |
| MCF 10A | Erlotinib | 19.9526 | uM | 7 | 156.25 | 15.92 | 36.00 | 194.50 | 0.1851 | 0.2536 |
| MCF 10A | 17-AAG | 0.0016596 | uM | 7 | 156.25 | 15.92 | 134.00 | 194.50 | 0.6890 | 0.8039 |
| MCF 10A | 17-AAG | 1 | uM | 7 | 156.25 | 15.92 | 28.00 | 194.50 | 0.1440 | 0.1693 |
| MCF 10A | Erlotinib | 0.1 | uM | 7 | 156.25 | 15.92 | 188.00 | 194.50 | 0.9666 | 0.9813 |
| MCF 10A | 17-AAG | 0.031623 | uM | 7 | 156.25 | 15.92 | 28.00 | 194.50 | 0.1440 | 0.1693 |
| MCF 10A | 0 | uM | 7 | 156.25 | 15.92 | 300.00 | 194.50 | 1.5424 | 1.2550 | |
| MCF 10A | Lapatinib | 3.1623 | uM | 7 | 156.25 | 15.92 | 228.00 | 194.50 | 1.1722 | 1.0900 |
| MCF 10A | 17-AAG | 0.01 | uM | 7 | 156.25 | 15.92 | 47.00 | 194.50 | 0.2417 | 0.3497 |
| MCF 10A | 0 | uM | 7 | 156.25 | 15.92 | 458.00 | 194.50 | 2.3548 | 1.5353 | |
| MCF 10A | Erlotinib | 10 | uM | 7 | 156.25 | 15.92 | 32.00 | 194.50 | 0.1645 | 0.2134 |